OliX PharmaceuticalsInc (226950) — Capital Reinvestment Ratio

Latest as of September 2025: 0.19x

OliX PharmaceuticalsInc (226950) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.23 Billion) in capital expenditures (₩623.14 Million). Check 226950 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.19x

Capex / Operating Cash Flow

Operating Cash Flow

₩3.23 Billion

KRW

Capital Expenditures

₩623.14 Million

KRW

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for OliX PharmaceuticalsInc (None–None)

Year-by-year Capital Reinvestment Ratio for OliX PharmaceuticalsInc from None to None. See OliX PharmaceuticalsInc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow